{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T05:54:08Z","timestamp":1715752448746},"reference-count":19,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/ol.2016.4737","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T07:52:10Z","timestamp":1466063530000},"page":"1019-1022","source":"Crossref","is-referenced-by-count":3,"title":["Rapid progression of mixed neuroendocrine carcinoma-acinar adenocarcinoma of the prostate: A case report"],"prefix":"10.3892","volume":"12","author":[{"given":"Jingchao","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuxun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leye","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"key20180108111539_b1-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"719","DOI":"10.6004\/jnccn.2014.0073","article-title":"Neuroendocrine prostate cancer: Subtypes, biology, and clinical outcomes","volume":"12","author":"Aggarwal","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"key20180108111539_b2-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2013.54.3553","article-title":"Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: Factors associated with time to development of NEPC and survival from NEPC diagnosis - a systematic review and pooled analysis","volume":"32","author":"Wang","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20180108111539_b3-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/pcan.2012.4","article-title":"A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008","volume":"15","author":"Marcus","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20180108111539_b4-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/annonc\/mdr004","article-title":"Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: Results of the French Genito-Urinary Tumor Group (GETUG) P01 trial","volume":"22","author":"Fl\u00e9chon","year":"2011","journal-title":"Ann Oncol"},{"key":"key20180108111539_b5-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V","article-title":"Treatment with cisplatin and etoposide in patients with neuroendocrine tumors","volume":"92","author":"Fj\u00e4llskog","year":"2001","journal-title":"Cancer"},{"key":"key20180108111539_b6-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminoncol.2006.10.026","article-title":"Unusual and underappreciated: Small cell carcinoma of the prostate","volume":"34","author":"Palmgren","year":"2007","journal-title":"Semin Oncol"},{"key":"key20180108111539_b7-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/jjco\/hys196","article-title":"Evaluation of the 7th American Joint Committee on cancer TNM staging system for prostate cancer in point of classification of bladder neck invasion","volume":"43","author":"Chung","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key20180108111539_b8-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4103\/1008-682X.123669","article-title":"Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation","volume":"16","author":"Lipianskaya","year":"2014","journal-title":"Asian J Androl"},{"key":"key20180108111539_b9-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1200\/JCO.2011.41.5166","article-title":"Challenges in recognizing treatment-related neuroendocrine prostate cancer","volume":"30","author":"Beltran","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180108111539_b10-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0022-5347(17)32417-5","article-title":"The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: A review and future directions in basic research","volume":"152","author":"Di Sant'Agnese","year":"1994","journal-title":"J Urol"},{"key":"key20180108111539_b11-ol-0-0-4737","first-page":"639","article-title":"Neuroendocrine differentiation in prostate adenocarcinoma","volume":"149","author":"Ram\u00edrez-Balderrama","year":"2013","journal-title":"Gac Med Mex"},{"key":"key20180108111539_b12-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1442-2042.2007.01616.x","article-title":"Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: A case report","volume":"14","author":"Kinebuchi","year":"2007","journal-title":"Int J Urol"},{"key":"key20180108111539_b13-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAS.0000000000000208","article-title":"Proposed morphologic classification of prostate cancer with neuroendocrine differentiation","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20180108111539_b14-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1442-2042.2001.00347.x","article-title":"Progression of prostate cancer to neuroendocrine cell tumor","volume":"8","author":"Tanaka","year":"2001","journal-title":"Int J Urol"},{"key":"key20180108111539_b15-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/pcan.2012.4","article-title":"A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008","volume":"15","author":"Marcus","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20180108111539_b16-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.urolonc.2005.08.022","article-title":"Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: A case report and short literature review","volume":"24","author":"Yashi","year":"2006","journal-title":"Urol Oncol"},{"key":"key20180108111539_b17-ol-0-0-4737","first-page":"240","article-title":"Systematic hormone- and chemotherapy in the management of skeletal metastases","volume":"27","author":"Reichardt","year":"1998","journal-title":"Orthopade"},{"key":"key20180108111539_b18-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4103\/1008-682X.123669","article-title":"Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation","volume":"16","author":"Lipianskaya","year":"2014","journal-title":"Asian J Androl"},{"key":"key20180108111539_b19-ol-0-0-4737","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fonc.2014.00295","article-title":"The evolution of prostate cancer therapy: Targeting the androgen receptor","volume":"4","author":"Aragon-Ching","year":"2014","journal-title":"Front Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4737\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:02:55Z","timestamp":1515423775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,16]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/ol.2016.4737"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4737","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}